BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20835733)

  • 1. Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.
    Ishigami M; Kamei H; Nakamura T; Katano Y; Ando H; Kiuchi T; Goto H
    J Gastroenterol; 2011 Mar; 46(3):367-77. PubMed ID: 20835733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
    Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver].
    Cui Y; Lu W; Gao W; Dong C; Han C; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Oct; 29(10):926-930. PubMed ID: 29017655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful active immunization using a hepatitis B virus vaccination protocol for a recipient with hepatitis B core antibody-positive liver graft.
    Ohno Y; Mita A; Ikegami T; Masuda Y; Urata K; Nakazawa Y; Kobayashi A; Miyagawa S
    Transplant Proc; 2014 Apr; 46(3):721-5. PubMed ID: 24767333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients.
    Park JB; Kwon CH; Lee KW; Choi GS; Kim DJ; Seo JM; Kim SJ; Joh JW; Lee SK
    Transpl Int; 2008 Apr; 21(4):346-52. PubMed ID: 18208419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
    Lin CC; Yong CC; Chen CL
    World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
    Holt D; Thomas R; Van Thiel D; Brems JJ
    Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW; Lee DS; Lee HH; Kim SJ; Joh JW; Seo JM; Choe YH; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2311-2. PubMed ID: 15561233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent incidence of escape mutants after successful hepatitis B vaccine response and stopping of nucleos(t)ide analogues in liver transplant recipients.
    Ishigami M; Honda T; Ishizu Y; Onishi Y; Kamei H; Hayashi K; Ogura Y; Hirooka Y; Goto H
    Liver Transpl; 2014 Oct; 20(10):1211-20. PubMed ID: 24961506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active immunization against de novo hepatitis B virus infection in pediatric patients after liver transplantation.
    Chang SH; Suh KS; Yi NJ; Choi SH; Lee HJ; Seo JK; Lee KU
    Hepatology; 2003 Jun; 37(6):1329-34. PubMed ID: 12774011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
    Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
    Dong C; Gao W; Ma N; Sun C; Zheng WP; Wang K; Shen ZY
    Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 27933716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.